Please Scroll Down to See Forums Below 
Starting my sarms triple stack in 2 weeks but was wondering if anyone had any insight on this article.
2004 article in The Wall Street Journal noted that a study published in Nature Medicine had found that GW501516 increased polyps in specially-bred mice,[3][31] but GSK originally said that they had not identified any safety problems with the compound and would continue to develop it.[14] However, researchers from GSK later presented findings of the adverse effects of giving GW501516 to rats and mice for two years at the 2009 meeting of the Society of Toxicology. The compound was found to significantly increase the chances of developing cancer and development of the drug was subsequently halted.[32][33][34]
In 2013 New Scientist reported that "tests on rats showed that at all doses, the drug rapidly causes cancers in a multitude of organs, including the liver, bladder, stomach, skin, thyroid, tongue, testes, ovaries and womb."[4] In 2013, WADA took the rare step of warning potential users of the compound of the possible health risks. They stated "clinical approval has not, and will not be given for this substance".[2][24]
2004 article in The Wall Street Journal noted that a study published in Nature Medicine had found that GW501516 increased polyps in specially-bred mice,[3][31] but GSK originally said that they had not identified any safety problems with the compound and would continue to develop it.[14] However, researchers from GSK later presented findings of the adverse effects of giving GW501516 to rats and mice for two years at the 2009 meeting of the Society of Toxicology. The compound was found to significantly increase the chances of developing cancer and development of the drug was subsequently halted.[32][33][34]
In 2013 New Scientist reported that "tests on rats showed that at all doses, the drug rapidly causes cancers in a multitude of organs, including the liver, bladder, stomach, skin, thyroid, tongue, testes, ovaries and womb."[4] In 2013, WADA took the rare step of warning potential users of the compound of the possible health risks. They stated "clinical approval has not, and will not be given for this substance".[2][24]
